We are live on ! Find out more
RCAG

Rehmann Capital Advisory Group Portfolio holdings

AUM $1.92B
1-Year Est. Return 16.97%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+16.97%
3 Year Est. Return
+51.41%
5 Year Est. Return
+57.24%
10 Year Est. Return
AUM
$689M
AUM Growth
+$46.6M
Cap. Flow
+$407M
Cap. Flow %
59.12%
Top 10 Hldgs %
30.04%
Holding
2,321
New
235
Increased
698
Reduced
686
Closed
210
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
1976
Amkor Technology
AMKR
$13.7B
$962 ﹤0.01%
+112
New +$1.02K
LUMO
1977
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$962 ﹤0.01%
+22
New +$1.01K
ACM icon
1978
Aecom
ACM
$9.75B
$958 ﹤0.01%
29
-797
-96% -$27.3K
HAYN
1979
DELISTED
Haynes International, Inc.
HAYN
$955 ﹤0.01%
26
APTS
1980
DELISTED
Preferred Apartment Communities, Inc.
APTS
$951 ﹤0.01%
56
-47
-46% -$692
HQCL
1981
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$950 ﹤0.01%
147
+126
+600% +$883
WIRE
1982
DELISTED
Encore Wire Corp
WIRE
$949 ﹤0.01%
20
COKE icon
1983
Coca-Cola Consolidated
COKE
$12.8B
$946 ﹤0.01%
+70
New +$1.03K
CHEF icon
1984
Chefs' Warehouse
CHEF
$4.5B
$941 ﹤0.01%
33
-29
-47% -$760
CPER icon
1985
United States Copper Index Fund
CPER
$772M
$936 ﹤0.01%
+50
New +$985
MSGS icon
1986
Madison Square Garden
MSGS
$9.39B
$931 ﹤0.01%
4
ZGNX
1987
DELISTED
Zogenix, Inc.
ZGNX
$928 ﹤0.01%
+21
New +$866
TR icon
1988
Tootsie Roll Industries
TR
$2.98B
$926 ﹤0.01%
+38
New +$877
AMRX icon
1989
Amneal Pharmaceuticals
AMRX
$5.79B
$919 ﹤0.01%
+56
New +$983
WMK icon
1990
Weis Markets
WMK
$1.86B
$907 ﹤0.01%
+17
New +$840
FMBH icon
1991
First Mid Bancshares
FMBH
$1.36B
$904 ﹤0.01%
23
-7
-23% -$265
TVTX icon
1992
Travere Therapeutics
TVTX
$5.78B
$900 ﹤0.01%
+33
New +$879
MNTA
1993
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$900 ﹤0.01%
44
-9
-17% -$193
NAK
1994
Northern Dynasty Minerals
NAK
$958M
$891 ﹤0.01%
1,645
SNR
1995
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$886 ﹤0.01%
+117
New +$930
QRVO icon
1996
Qorvo
QRVO
$8.74B
$882 ﹤0.01%
11
CPK icon
1997
Chesapeake Utilities
CPK
$3.21B
$879 ﹤0.01%
11
-771
-99% -$58.8K
CZNC icon
1998
Citizens & Northern Corp
CZNC
$455M
$879 ﹤0.01%
+34
New +$852
NKTR icon
1999
Nektar Therapeutics
NKTR
$2.58B
$879 ﹤0.01%
+1
New +$1.15K
AROW icon
2000
Arrow Financial
AROW
$652M
$874 ﹤0.01%
29

Similar funds

Rehmann Capital Advisory Group's Q2 2018 Portfolio in Review

As of Q2 2018, Rehmann Capital Advisory Group held 2,321 positions worth $689M, up 7.2% from $642M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rehmann Capital Advisory Group deployed $407M of net new capital in Q2 2018, opening 235 new positions and adding to 698 existing holdings. Its largest new stake was Fidelity MSCI Real Estate Index ETF: 36,620 shares worth $899K.

By sector, the portfolio is most concentrated in Consumer Staples at 6.2% of assets, down from 6.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Trust Value Line Dividend Fund, an estimated $2.21M trimmed.

  • Rehmann Capital Advisory Group's largest Q2 2018 buy was Fidelity MSCI Real Estate Index ETF: 36,620 shares worth $899K.
  • Rehmann Capital Advisory Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $248M increase.
  • Rehmann Capital Advisory Group's biggest Q2 2018 reduction was First Trust Value Line Dividend Fund, cutting an estimated $2.21M.
  • Rehmann Capital Advisory Group fully exited Monsanto Co in Q2 2018, selling an estimated $771K.
  • Rehmann Capital Advisory Group's ten largest holdings make up 30% of its $689M portfolio in Q2 2018.
  • Rehmann Capital Advisory Group opened 235 new positions and closed 210 in Q2 2018.
  • Rehmann Capital Advisory Group's portfolio value rose 7.2% quarter-over-quarter to $689M.

Based on Rehmann Capital Advisory Group's 13F filing for Q2 2018, filed 20 Sep 2018.